Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence

Apoorv Kirti,Faizan Zarreen Simnani,Snehasmita Jena,Sudakshya S Lenka,Chethana Kalalpitiya,Shaikh Sheeran Naser,Dibyangshee Singh,Anmol Choudhury,Rudra Narayan Sahu,Anu Yadav,Adrija Sinha,Aditya Nandi,Pritam Kumar Panda,Nagendra Kumar Kaushik,Mrutyunjay Suar,Suresh K Verma

DOI: https://doi.org/10.1016/j.canlet.2024.216990

2024-07-10

Abstract:Current methods of cancer therapy have demonstrated enormous potential in tumor inhibition. However, a high dosage regimen of chemotherapy results in various complications which affect the normal body cells. Tumor cells also develop resistance against the prescribed drugs in the whole treatment regimen increasing the risk of cancer relapse. Metronomic chemotherapy is a modern treatment method that involves administering drugs at low doses continuously, allowing the drug sufficient time to take its effect. This method ensures that the toxicity of the drugs is to a minimum in comparison to conventional chemotherapy. Nanoparticles have shown efficacy in delivering drugs to the tumor cells in various cancer therapies. Combining nanoparticles with metronomic chemotherapy can yield better treatment results. This combination stimulates the immune system, improving cancer cells recognition by immune cells. Evidence from clinical and pre-clinical trials supports the use of metronomic delivery for drug-loaded nanoparticles. This review focuses on the functionalization of nanoparticles for improved drug delivery and inhibition of tumor growth. It emphasizes the mechanisms of metronomic chemotherapy and its conjunction with nanotechnology. Additionally, it explores tumor progression and the current methods of chemotherapy. The challenges associated with nano-based metronomic chemotherapy are outlined, paving the way for prospects in this dynamic field.